Kamada Ltd. Reports Substantial Growth in 2024
Company Announcements

Kamada Ltd. Reports Substantial Growth in 2024

Kamada (KMDA) has released an update.

Kamada Ltd. has announced robust financial results for the first half of 2024, showing an 18% increase in six-month revenue and a significant 68% rise in profitability. The strong performance, driven by increased sales of FDA-approved products and successful market penetration in the U.S., has led the company to reiterate its full-year revenue guidance of $158 million to $162 million, with an adjusted EBITDA forecast of $28 million to $32 million. Cash flow from operating activities also reflected positive growth, reinforcing the company’s financial health.

For further insights into KMDA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskKamada’s Strong Growth and Strategic Expansion in 2024
TheFlyKamada reports Q3 EPS 7c, consensus 7c
TheFlyKamada sees FY24 revenue $158M-$162M, consensus $160.47M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App